15

018673

| 29 | -- 2013

(.....): 99, 115 27,

,
14-17
2013

.....

6 |
6 | 

7 | .....
7 |

8 | 6 .....
9 |
14 | .....
16 |
18 | (Posters)
21 | 6

22 |

24 |
24 | :

27 | 

27 | 

28 | -
28 | 

31 | -

| 29
- 2013
.....
:
:
. :
:
:
:
: , ,

.....
99, 115 27,
./fax: 210 7753104
e-mail: pefni@ath.forthnet.gr
http://www.pefni.gr
I


-

K

, ,
,

,
.

.




.

31 |  (ESCP)

:
, ,
,

34 | 9 () ,

42 |  (TransAtlantic-TACD): :

:
PressiousArvanitidis
& :

.: 210 28.29.552, 28.43.871



(.....)

!

2014



!

- - 2013

, 09.12.2013
. .: 507
:
1) .
2) . .. . .
:
:

,
. ,

.. (.. 112/89 7 . 1 . - 49/10-2-89),

, .
(.. 108/1993, . ,
..)
.
(, ..)
(.. , , ..).
-

, ,

.
, .....
, .
.
,
.


.
..

 .. . .

.
.

 .....

().
,
()
2014.

14/1/2014,

2014
.


.

. 3580/2007 ( 10 .
3 )

.
, ,

.
(.3846/2010, .3867/2010,
. 3918/2011, .4118/2013, . .
6881/2012 ..)
.

,
.


,
.

.. 4199/2-82013

2014, . . 5239/7-10-2013 ,
( !!!)
2014.
,
15

.
.....

( ..
486/8-8-2013)
( .. 486/8-8-13),

2014

.

2014 ,
,
,
- ,
,

.
,
(AGORA), !!!
2014
,
.
,
, , ,

, .

- - 2013

6 .....

:

14-17 2013,

14 2013
17.30-19.00:

19.00: . :

19.00-19.30: & ..
19.30-20.00: Roberto Frontini EAHP
:
20.00-20.30: .....

:

15 2013
: 10.00..-15.00..

: ,
: - Evidence Based Practice (E.B.P.)
-

:
10.00-10.30: ( , .. ):


10.30-11.00: (MD, , . ):


11.00-11.30: ( , ,
):

Evidence Based Practice (...) .
11.30-12.00: ( )


12.00-12.30:

- - 2013

6 .....

12.30-13.00: ( )


13.00-13.30: ( , .. ):

(...)
13.30-14.00: ( - Univadis and Online Strategy & Solutions Manager):

.
UNIVADIS
14.00-15.00: , ,
( .....)

17.30-20.30
: ,
17.30-18.30:
18.30-19.00:

: ( MSc, )
19.00-19.30:
19.30-20.00: HIV -

HIV .


: ( - )
20.00-20.30:

16 2013
: 10.00..-14.30..
: ,
10.00-12.00: :
/

/

:
. (- BScHS, BScEcon, MSc, PhD) . (
.. . . ) . ( .. ... . )

10

6 .....

11.30-12.00: , ,
12.00-12.30:
12.30-13.30: : , ,

 /




:
( , .. .. )

( , .. .. )

13.30-14.00: ,
14.00-14.30: : .


: ...
)

-

17.30-20.30
: ,
: :
17.30-17.50: ( ...)

...
17.50-18.10: ( 1 )

..
18.10-18.30: ( )


18.30-18.50:
18.50-19.10: ( )

,
19.10-19.30: ( , )


19.30-19.50: (, ...)


19.50-20.30: , ,

- - 2013

11

6 .....

17 2013
09.30-11.00: 6 .....

11.00:

:
..
(.....)
:

. :

, ,

Pfizer Novartis Astellas Glaxo Teva Leo Gilead Vianex Amgen AstraZeneca Elpen SD Baxter Unipharma

Novonordisk Roche Fresenius-Kabi Pharmathen Bayer Takeda Demo Bristol-Myers Squibb Cooper

Vocate Boehringer Ing. Medhel Hellas - Balu Vioser Janssen-Cilag Pharmazac

12

6 .....

- 2013

13

6 .....

.....
, , ,

.....

.




,

. ,
,

,
.

,
,
.

124 220
(1/172
2012), 25
. 10 ,

.


,

, ,
.

, , .

,
,
, -
, , ,

.

-

14

,
,
, ,

( , , ,

,
) .



,

(.. ,
, , , , ..)
.
,
...,
,

.


...
108/93, . 2519/21-8-97 ( 165
')
... .


(>6) .. , , .
.



,
(Esynet, Agora, Adam, , be24).
 .
 .

-

6 .....

,
, ,
... .
.....

108/93 (
).
,
..... . (
).
, , 6 ,
108/93
.
( 2 ),
.....
.

,

, , ,
...
!
. ,

,
.
, ,
.

, ( )
. ,
,

, ...

,

,
,

, . ,
,



,

10 .
,

.


,

.
, ,


, ..

,


.



,
,

. ,
, !!!

, !

- - 2013

15

6 .....

,
..... .
2
: - (E.B.P.).

, . ,
... .
,
.

14-17 2013
6 . , ,
,

. ...,
....
.
.
.

3 .
1 , , . , ... .
EAHP R. Frontini,
, , . .
, . -

16

,
,

.
. , . .
,
(E.B.P.).

,
.
UNIVADIS,
.
,
. , ,

.
,
,
.
, ,

6 .....

. , , .
-
. , HIV
, , ,
,
.

.

3 : . ,
, .
, : )
( ,
, ), ) ( , , /
DRGS), ) (, , ).
. .
(.. )
( , ,
, ).
,
,
, . .
, poster . ,

, ,

.

Poster PowerPoint.


,
.
12 de Octubre - .
: .
.
,
, ( ), 12 ,
.
,
,
.., .
- - 2013

17

6 .....

: : .

.


... . .
,
.... . .
, - . ,

,
.

1 . ..
.

.

, . , ,


.....
.
: -

(Posters)
, , (posters), .
:
. , . , .. , . , , ..
: 4 : , ,
.
, , 1995 2013.
: : 768 1655 471 , .
80,5% , : 19,5% , 43,9%
, 0,7% 26,8% . 2013 1995 (p<0.05) : ,
( 2013).
:
.
:

18

6 .....

:
, ,
: INR (International
Normalized Ratio)
:
:
i.  : ( ..), ( ..),
( ..), ( ..), ( ..), ( ).
ii.  : ( ..).
:
i.  : , , ..
ii.  : , ..
.
:
:
. , . , . , . , .
Cooley

. -
. ,
6-9 .
.
,
.
, 3.200 ,
8% ( 20%).
200
5 . 180 20 .
,
.

. , ,
. 102 ,
, (, , ).

.
:
- - 2013

19

6 .....

: BURNOUT

. , . , .
. ,
, .
,
, .

, .

.
.
Maslach, .
, ,
, , , , , ,
.., .
, .
:

,
'
6 .....


,

.

20

6 .....

- - 2013

21

6 .....

22

6 .....

- - 2013

23

:
...:


(...)
: , 18 2013,

.
...

.


.
, ...

24

(...) (..),


.
, ...
, ,
, ,
.

, , , :

 , ,

, -

 (, )
(...) , .

:


 ( )
,
.
... .


.
.. ,
.
.
, . ( -
) . ( ).
...
( ) ... . , .
.

. - . ... , , ,

""

...


, .

- - 2013

25

26

, ,
:

1)  .. .
2) 
,
.
3)
 .

4)
 .
5)  ....



.


...., .
 , , (
)
. , ,

(.. , , ..).

, ,
/
.
 ,

, .
:
.. ..

- - 2013

27

Msc

900 , .
20-40% ,
, .

: .

: (HBV, HCV) ,
.

: P450 . .

: .. HIV, ,
.

:
, ..
.

:
, ,
.

28

:
.

( , ).

:
, (
) .

. -

(): ,

( 1 1 ). (..
amoxicillin, clavulanic acid). .

vs

1 - 6

1 - 1

, ,

) : , ,
, .

) ():

.
.

ALT > 3ULN & ALT / ALP > 5

) : (.. )

.

(, , , , ,
).
(, , )
.

ALP > 2ULN & ALT / ALP < 2

) (/): .

.
-.

ALT > 3ULN & ALP > 2ULN & ALT / ALP > 2 <5

- - 2013

29

()

allopurinol, diclofenac, dihydralazine, gemander,

halothane, methyldopa, minocycline, nevirapine,
phenytoine, propylthiouracil, trovafloxacin

acarbose, amiodarone, bosentan, dantrolene,

diclofenac, disulfiram, felbamate, flutamide,
HAART, statins, isoniazide, ketoconazole, labetalol,
leflunomide, methotrexate, nefazodone,
nevirapine, nicotinic acid, paracetamol, pemoline,
pyrazinamide, rifampicin, tacrine, tolcapone,
troglitazone, sodium valproate, ximelagatran,
zafirlukast, zileutin

()

-, amitriptilline, amoxicillin/clavulanic acid,

carbamazepine chlorpromazine, cotrimoxazole,
erythromycin, phenobarbital, sulfonamides,
sulindac,

, ,
azathioprine, cyclosporine, estrogens, terbinafine

methotrexate

()

allopurinol, amoxicillin/clavulanic acid,

carbamazepine, hydralazine, methyldopa,
penicillamine, phenylbutazone, phenytoin,
procainamide, quinidine, sylfonamides
nucleoside reverse transcriptase inhibitors, ,
sodium valproate

, danazol

amiodarone, tamoxifen,

amiodarone

Budd-Chiari

Peiliosis Hepatis

, , azathioprine

methotrexate, vit.

busulfan, cyclophosphamide
:

:
1. . Kaplowitz, Drug-Induced Liver Injury. Clin Inf Diseases 2004;38(2):44-8.
2. M.Ghabril, N. Chalasani, E. Bjornsson, Drug-Induced Liver Injury: a clinical update. Curr Opin Gastroenterol 2010;26(3):222-226
3. www.gastro.ucsd.edu/.../DrugInducedLiverInjury

30

(ESCP)
, 16-18 2013
42 16-18
2013.
,
. 3
,
.

,
PhD
.
.
( 30
).
.
:
1. 

,
.
2.  (
,
). .
3. 
,
.
, ,
, -

, .

,

.
.

,

ESCP (SIGs-Special Interest Groups).
17
,
,

.

.

.
,
,
. HER2(+)
(.. pertuzumab, trastuzumab-DM1).
18 :

, , ,
..

. . - , .
,
, , ,
- - 2013

31

, ..,
.

poster :
.

-.

-.

, .

, , ,

:
Msc

Clinical Research Conference: : ,
15 & 16 2014, (.
103-105),

5 : : ,
25 26 2014,
e-Health, 12-14 2014,

EFGCP Annual Conference 2014: Benefits and Risks of Research: How Do We Redress the Current
Imbalance?, 28-29 January 2014, Brussels
1 : ,
30 - 1 2014, ,
19o EAHP, 26-28 2014,
International Society of Pharmacovigilance (ISOP): Proactive Pharmacovigilance, Risk Management
and Pharmacovigilance in the Era of Personalised Medicine, 3-4 April 2014, Zagreb, Croatia
19 ,
8-11 2014, ,

32

9 () ,

, 5-7 2013
9 ,
, : 30
. 5-7 2013 Hilton .

. ,
(..),
forum
(eHealth) 12-14 2014 .
. . , ,

..,
.

34

,
.., . . .


.
eHealth .
. ,

, .

.

, ,


. :
21 .
, . .

,

.


.

. . , -
.
, . . , (),
.
. . , . ,

,
check up.
, . , ,

.
:

,


. .
, ,

,
80%
. :

.
workshop
: Alma Ata
. . . ,
,
()
. . .
,
, ,
,
. , . .

- - 2013

35

,

.
,

.
. . ,

,
.
:
. , . . , Sanofi,

.
. . ,

, ,
... ,
,
,

.
,

,
. . .

36

(Health Technology Assessment - HTA).
,
,
.
,
,


.
. . ,
pay-forperformance
.
, .
.
:
,
.
, ex officio
.
.
. , .
... CHMP COMP, ,

. - .
-
.
...
/ .
: ,
. . , Euromedica ,
,

, .
. . .
. Ansgar Hebborn,
Head market access policy Roche,

,
,

.

.
. . ,

38

, :

;
. . . ,
,

. , . ,
, ,


.

: :
.
, 1,5 , ,
(
).


.

,

, .
. . ,
Interamerican Insurance Europe,

. , ,

,

.
: ;
. , ,
,

,

. . . ,
- ,
,
,
.
,
. . ,
. . -



.

,
. , . .
.. - , ..
.
.
. . ,

,
: Logistics .
, . , . , .-.
.

:
.
( )

.


.
: ,

- - 2013

39

poster
9
9
. , . . :
.

40

- - 2013

41

(TransAtlantic-TACD):
:

, , 13 2013

, Trans-Atlantic Consumer Dialogue (TACD)

( ), 13 2013 : : H .
:
) 
(Access to Medicines)
) 
)  .

,

, ,


(advocacy capacity-building).

42

31 2013 : ;

.